# Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease

> **NCT06992804** · EARLY_PHASE1 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 20 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** NirsCure with Lecanemab
- **OTHER:** sham NirsCure with Lecanemab
- **OTHER:** NirsCure with Lecanemab

## Key facts

- **NCT ID:** NCT06992804
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-28
- **Primary completion:** 2025-10-15
- **Final completion:** 2027-01-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06992804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06992804, "Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06992804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*